Navigation Links
3D Biomatrix Technology Recognized by NC3Rs 3Rs Prize
Date:3/26/2013

Ann Arbor, MI (PRWEB) March 26, 2013

3D Biomatrix, a leader in three-dimensional (3D) cell culture products, is pleased to announce that the paper first describing the company’s Perfecta3D® Hanging Drop Plates was declared runner up in the National Centre for the Replacement Refinement & Reduction of Animals in Research (NC3Rs) 3Rs Prize. The prestigious 3Rs prize is an annual prize for original and recent papers that contribute to scientific and technological advances in the replacement, refinement, and reduction of animals in research.

The Perfecta3D Hanging Drop Plates allow for easy production of spheroids, which are micro-scale 3D tissues that mimic avascular tissues, tumors, and embryoid bodies. Spheroids allow life science researchers to work in an environment that simulates the three dimensions of the human body, prior to animal testing, better than existing two-dimensional (2D) cell culture techniques for early screening and testing. With one spheroid per well, the plates facilitate the formation, culture, and testing of 3D spheroids and stem cell aggregates, including embryoid bodies, in a standard 96- or 384-well plate format without the aid of coatings or matrices. They are easy to use, and cell growth can be monitored regularly. Applications of the plates include cancer research and drug development, toxicology testing, and stem cell research.

The esteemed paper, published in the journal Analyst [1] in 2011, describes the Perfecta3D Hanging Drop Plates and their use in generating spheroids from several cell types. The paper also describes the use of the spheroids to test several anti-cancer drugs directly in the plates. Remarkably, 3D spheroids displayed responses to the drugs that were much more realistic than those of 2D cell cultures. Inclusion of similar experiments i
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. 3D Biomatrix Announces Stipend to Present at Spring 2013 Conferences
2. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
3. Positive Clinical Study Results for BSPs HyperQ Technology
4. Arizona State University engineers aim to improve performance of technology in extreme environments
5. iBioLaunch™ Technology Successfully Applied to Modified C1 Inhibitor
6. Pitt discoveries in quantum physics could change face of technology
7. Verenium to Present at Baird Clean Technology Conference
8. Puma Biotechnology Announces Completion of Private Placement
9. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
10. Animal Biotechnology - Technologies, Markets and Companies
11. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... . , Electrical ... a new kind of building block for digital integrated ... be based on three-dimensional arrangements of nanometer-scale magnets instead ... semiconductor industry CMOS fabrication of silicon chips ... the University of Notre Dame are exploring "magnetic computing" ...
(Date:9/30/2014)... NEW YORK , Sept. 30, 2014 /PRNewswire/ ... trends and segments with highest potential revenues Do ... Visiongain,s updated report gives you revenue predictions for ... ahead. For those therapies you find financial data, ... new analysis you get sales forecasts to 2024 ...
(Date:9/30/2014)... the last decade, the laboratory filtration market is experiencing ... acceptance of new filtration technologies in end users market. ... catalyzing the growth of laboratory filtration market. , The ... a strong CAGR during the forecast period of 2014-2019 ... 2019. The market is mainly driven by the increasing ...
(Date:9/30/2014)... Md. , Sept. 30, 2014  RegeneRx ... today announced that it has received a Canadian ... by Actin-Sequestering Peptides.  This patent includes claims using ... numerous other actin-sequestering peptides for these purposes.  The ... About RegeneRx Biopharmaceuticals, Inc. ( www.regenerx.com ) ...
Breaking Biology Technology:A new dimension for integrated circuits: 3-D nanomagnetic logic 2A new dimension for integrated circuits: 3-D nanomagnetic logic 3Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 2Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 3Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 4Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 5Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 2Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 3Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 4Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 5RegeneRx Receives Canadian Patent for Inhibition or Reversal of Skin Aging 2
... Inovail, successfully launches ... OmegaGen(R) in Australia and New Zealand, LAVAL, QC, ... (NASDAQ.NEPT - TSX.V.NTB) and its commercial,pharmaceutical partner Inovail Pty ... complementary medicine in Australia and New,Zealand. Neptune foresees this ...
... BASINGSTOKE, England, March 25 Shire plc,(LSE: SHP, ... preliminary results prepared under International Financial,Reporting Standards ("IFRS") ... On February 21, 2008 Shire announced its ... Notes to Editors, Shire plc, Shire,s ...
... IRVINE, Calif., March 25 Masimo (Nasdaq:,MASI), ... Motion and Low,Perfusion pulse oximetry, today announced ... manufacturer and supplier of,electrocardiographs, spirometers, patient monitors ... SET technology platform as,the foundational technology of ...
Cached Biology Technology:Neptune Technologies expands into medicinal markets in Asia Pacific 2Neptune Technologies expands into medicinal markets in Asia Pacific 3Shire plc: IFRS Results for the Year Ending December 31, 2007 2Shire plc: IFRS Results for the Year Ending December 31, 2007 3Shire plc: IFRS Results for the Year Ending December 31, 2007 4Shire plc: IFRS Results for the Year Ending December 31, 2007 5Shire plc: IFRS Results for the Year Ending December 31, 2007 6Shire plc: IFRS Results for the Year Ending December 31, 2007 7Shire plc: IFRS Results for the Year Ending December 31, 2007 8Shire plc: IFRS Results for the Year Ending December 31, 2007 9Shire plc: IFRS Results for the Year Ending December 31, 2007 10Shire plc: IFRS Results for the Year Ending December 31, 2007 11Shire plc: IFRS Results for the Year Ending December 31, 2007 12Shire plc: IFRS Results for the Year Ending December 31, 2007 13Shire plc: IFRS Results for the Year Ending December 31, 2007 14Shire plc: IFRS Results for the Year Ending December 31, 2007 15Shire plc: IFRS Results for the Year Ending December 31, 2007 16Shire plc: IFRS Results for the Year Ending December 31, 2007 17Shire plc: IFRS Results for the Year Ending December 31, 2007 18Shire plc: IFRS Results for the Year Ending December 31, 2007 19Shire plc: IFRS Results for the Year Ending December 31, 2007 20Shire plc: IFRS Results for the Year Ending December 31, 2007 21Shire plc: IFRS Results for the Year Ending December 31, 2007 22Shire plc: IFRS Results for the Year Ending December 31, 2007 23Shire plc: IFRS Results for the Year Ending December 31, 2007 24Shire plc: IFRS Results for the Year Ending December 31, 2007 25Shire plc: IFRS Results for the Year Ending December 31, 2007 26Shire plc: IFRS Results for the Year Ending December 31, 2007 27Shire plc: IFRS Results for the Year Ending December 31, 2007 28Shire plc: IFRS Results for the Year Ending December 31, 2007 29Shire plc: IFRS Results for the Year Ending December 31, 2007 30Shire plc: IFRS Results for the Year Ending December 31, 2007 31Shire plc: IFRS Results for the Year Ending December 31, 2007 32Shire plc: IFRS Results for the Year Ending December 31, 2007 33Schiller AG Adopts Masimo Rainbow SET as Their Technology Platform of Choice for Patient Monitoring Devices Worldwide 2
(Date:9/30/2014)... what goes wrong with your muscles because of age, disease ... actually is. That,s where a new research report published in ... comes in. In the report, a team of ... can help scientists "see" which genes are active in an ... gene activity and that men have approximately 400 more active ...
(Date:9/30/2014)... Mass. , Sept. 30, 2014 /PRNewswire/ ... control solutions for the biotech and power ... its new RECONN Bioprocess Manager, an easy-to-use ... solution geared towards bioprocess development laboratories. ... have disparate bioreactor and analyzer systems. Accessing ...
(Date:9/30/2014)... 30, 2014 Winners of The Economist,s prestigious ... scheduled to take place at the JW Marriott Hong Kong on ... winners will share their experiences and the lessons those hold for ... proven innovation over the past decade, will be presented at a ... the summit. It will be the first time the ceremony has ...
Breaking Biology News(10 mins):Scientists identify which genes are active in muscles of men and women 2Spectra Automation Introduces RECONN Bioprocess Manager 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 3Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 4Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 5Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 6Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 7
... WASHINGTON, N.C. , Oct. 21, 2013 Washington Eye Center ... Eye Care, effective immediately. The name was chosen to better reflect ... come to expect from Eastern North Carolina,s ... Eye Care will be the new name of the locations in ...
... map shows that most tropical rain falls in the Northern ... inches of rain a year, while an equal distance on ... long believed that this was a quirk of the Earth,s ... planet spins pushed tropical rain bands north of the equator. ...
... researchers used suction to learn that individual "molecular muscles" within ... may explain how cells "feel" the environment and appropriately adapt ... published online Oct. 20 in the journal Nature Materials ... are translated into internal signals. A computer model ...
Cached Biology News:Washington Eye Center is now Precision Eye Care 2Global ocean currents explain why Northern Hemisphere is the soggier one 2Cells' 'molecular muscles' help them sense and respond to their environments 2Cells' 'molecular muscles' help them sense and respond to their environments 3
... temperature control for microbiology and cell culture. ... is suitable for DASGIP bioreactors from 150 ... temperature ranges from approximately 10 °C to ... with an individual electrical heating element with ...
... gel stain is a sensitive nucleic acid ... to RNA and low background in gels, making ... polyacrylamide gels using laser scanners or standard UV ... mL unit size (S-7568) and a special packaging ...
... reports the data from any one of IITC ... recorder. The final data is sent from the ... is automatic for Systolic, Mean, Heart Rate while ... is always in the position to override the ...
Sirtuin 7 (SIRT7) Rabbit anti-Human Polyclonal Antibody Immunogen: Synthetic peptide - KLH conjugated Family: Other Recommended Storage: Long term: -20C; Short term: +4C...
Biology Products: